John Popko

Clinical Project Manager at Santalis Pharmaceuticals - San Antonio, TX, US

John Popko's Colleagues at Santalis Pharmaceuticals
John Popko's Contact Details
HQ
210-558-8896
Location
Georgetown, Texas, United States
Company
Santalis Pharmaceuticals
John Popko's Company Details
Santalis Pharmaceuticals logo, Santalis Pharmaceuticals contact details

Santalis Pharmaceuticals

San Antonio, TX, US • 5 - 9 Employees
Major Drugs

US-based Santalis Pharmaceuticals, Inc. is a wholly-owned subsidiary of Quintis Ltd. of Perth, Australia (ASX:QIN). Santalis was formed to develop a range of OTC and prescription products based on the botanical drug substance produced by Quintis' Santalum album trees. Santalis has the world-wide exclusive rights to Quintis' Sandalwood Album Oil (SAO) for healthcare uses. Quintis is the world's largest producer of this essential oil and is the only supplier of pharmaceutical grade SAO from sustainably-grown trees. Santalis is developing SAO under the FDA's botanical drug development guidelines, with a current focus on dermatology. Indications of particular interest include acne, rosacea, atopic dermatitis/eczema, psoriasis and viral skin diseases such as Molluscum contagiosum and warts caused by human papilloma virus (HPV).

N/A
Details about Santalis Pharmaceuticals
Frequently Asked Questions about John Popko
John Popko currently works for Santalis Pharmaceuticals.
John Popko's role at Santalis Pharmaceuticals is Clinical Project Manager.
John Popko's email address is ***@santalispharma.com. To view John Popko's full email address, please signup to ConnectPlex.
John Popko works in the Major Drugs industry.
John Popko's colleagues at Santalis Pharmaceuticals are Marianne Cronin and others.
John Popko's phone number is 210-558-8896
See more information about John Popko